A big recall for Boston Scientific | Cardiologist sentenced to 6.5 years in prison

This is a Class I recall, which means the issue can lead to serious injury or death.

“Our results strengthen the notion that a combination of mammographic features and other breast cancer risk factors could be a novel and affordable tool to assess cardiometabolic health in women attending mammographic screening,” researchers said.

He was also ordered to pay $1.2 million in restitution. 

Women have long been underrepresented in clinical trials related to cardiovascular health. What can researchers do to reverse that trend? 

The study's authors examined outcomes data from more than 8,500 tricuspid valve repairs and nearly 9,000 tricuspid valve replacements.

The team's convolutional neural network was trained on data that is readily available at most facilities. 

The trend is particularly noticeable in patients with a history of CVD or hypertension.

The last update to these guidelines was published in 2016. 

Researchers tracked data from nearly 2,500 patients from 15 different facilities, sharing their findings in the Journal of the American College of Cardiology.

A new clinical study is scheduled to begin in the near future. 

True or false? Each time a software developer significantly updates an FDA-approved Software as a Medical Device product, the SaMD faces possible re-review by the agency.